MISSISSAUGA, ON, Feb. 6, 2019 /CNW/ - Aralez Pharmaceuticals Inc. (the "Company") today announced that the Company has changed its name from "Aralez Pharmaceuticals Inc." to "Old API Wind-down Ltd." as required in accordance with, and pursuant to, the terms and conditions of the Share Purchase Agreement, dated September 18, 2018, as amended, by and among the Company, its former Canadian subsidiary Aralez Pharmaceuticals Canada Inc. and Nuvo Pharmaceuticals Inc.
Additional Information
Information about the Company and the court-supervised proceedings are available at a website administered by the Company's claims agent, Primeclerk, at https://cases.primeclerk.com/Aralez. Information is also available at a website maintained by Richter Advisory Group Inc., the Company's court-appointed monitor in Canada, in accordance with the Canadian court proceedings, at http://insolvency.richter.ca/A/Aralez-Pharmaceuticals.
SOURCE Aralez Pharmaceuticals Inc.
For further information: please call 1-877-676-4390 or e-mail at aralez@richter.ca.
Additional Information
Information about the Company and the court-supervised proceedings are available at a website administered by the Company's claims agent, Primeclerk, at https://cases.primeclerk.com/Aralez. Information is also available at a website maintained by Richter Advisory Group Inc., the Company's court-appointed monitor in Canada, in accordance with the Canadian court proceedings, at http://insolvency.richter.ca/A/Aralez-Pharmaceuticals.
SOURCE Aralez Pharmaceuticals Inc.
For further information: please call 1-877-676-4390 or e-mail at aralez@richter.ca.
